 39 PM / Updated 12 minutes ago BRIEF-Sun Pharmaceutical Industries Announces Settlement Of Patent Litigation For Generic Linzess In U.S. Reuters Staff 
Jan 16 (Reuters) - Sun Pharmaceutical Industries Ltd : 
* SAYS CO‘S UNITS HAVE REACHED AN AGREEMENT WITH IRONWOOD PHARMACEUTICALS, INC. AND ALLERGAN PLC 
* ANNOUNCES SETTLEMENT OF PATENT LITIGATION FOR GENERIC LINZES IN US 
* COMPANIES TO GRANT CO‘S UNITS LICENSE TO MARKET GENERIC VERSION OF LINZESS IN U.S FROM FEB 1, 2031 OR EARLIER UNDER CIRCUMSTANCES 
* ADDITIONAL DETAILS REGARDING THE SETTLEMENT WERE NOT DISCLOSED. Source text - bit.ly/2Dl8eOU  